Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Mahalati

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Annals of Transplantation|February 24, 2001
Pharmacological surrogates of allograft outcomeK Mahalati, B D Kahan
Clinical Pharmacokinetics|August 29, 2001
Clinical pharmacokinetics of sirolimusK Mahalati, B D Kahan
The Journal of Urology|December 22, 1999
Is 3-hour cyclosporine blood level superior to trough level in early post-renal transplantation period?K Mahalati, J Lawen, B Kiberd, et al.
Cancer|March 20, 1998
Methotrexate tolerance in patients with ileal conduits and continent diversionsS Srinivas, K Mahalati, F S Freiha
Urologia Internationalis|January 1, 1997
A modified BEP protocol: reduction of hospitalization without reducing the efficacyH Ozen, I Tekin, A Sahin, et al.
Pharmacology, Biochemistry, and Behavior|May 1, 1991
Oxytocin inhibits male sexual behavior in prairie volesK Mahalati, K Okanoya, D M Witt, et al.
Transplantation|July 31, 1999
Neoral monitoring by simplified sparse sampling area under the concentration-time curve: its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantationK Mahalati, P Belitsky, I Sketris, et al.
Journal of Clinical Apheresis|June 4, 1999
Predictable recovery from myasthenia gravis crisis with plasma exchange: thirty-six cases and review of current managementK Mahalati, R B Dawson, J O Collins, et al.
Transplantation|November 4, 2000
Conversion to rapamycin immunosuppression in renal transplant recipients: report of an initial experienceJ Dominguez, K Mahalati, B Kiberd, et al.
BJU International|April 22, 1999
The management of brain metastasis in nonseminomatous germ cell tumoursK Mahalati, C Y Bilen, H Ozen, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Annals of Transplantation|February 24, 2001
Pharmacological surrogates of allograft outcomeK Mahalati, B D Kahan
Clinical Pharmacokinetics|August 29, 2001
Clinical pharmacokinetics of sirolimusK Mahalati, B D Kahan
The Journal of Urology|December 22, 1999
Is 3-hour cyclosporine blood level superior to trough level in early post-renal transplantation period?K Mahalati, J Lawen, B Kiberd, et al.
Cancer|March 20, 1998
Methotrexate tolerance in patients with ileal conduits and continent diversionsS Srinivas, K Mahalati, F S Freiha
Urologia Internationalis|January 1, 1997
A modified BEP protocol: reduction of hospitalization without reducing the efficacyH Ozen, I Tekin, A Sahin, et al.
Pharmacology, Biochemistry, and Behavior|May 1, 1991
Oxytocin inhibits male sexual behavior in prairie volesK Mahalati, K Okanoya, D M Witt, et al.
Transplantation|July 31, 1999
Neoral monitoring by simplified sparse sampling area under the concentration-time curve: its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantationK Mahalati, P Belitsky, I Sketris, et al.
Journal of Clinical Apheresis|June 4, 1999
Predictable recovery from myasthenia gravis crisis with plasma exchange: thirty-six cases and review of current managementK Mahalati, R B Dawson, J O Collins, et al.
Transplantation|November 4, 2000
Conversion to rapamycin immunosuppression in renal transplant recipients: report of an initial experienceJ Dominguez, K Mahalati, B Kiberd, et al.
BJU International|April 22, 1999
The management of brain metastasis in nonseminomatous germ cell tumoursK Mahalati, C Y Bilen, H Ozen, et al.
Pageof 2